1,3-Oxathiane, 2-ethyl-4,4-dimethyl-
Common Name: |
1,3-Oxathiane, 2-ethyl-4,4-dimethyl- |
IUPAC Name: |
2-ethyl-4,4-dimethyl-1,3-oxathiane |
Molecular Formula: |
C11H18O2 |
SMILES: |
CCC1OCCC(S1)(C)C |
Inchi: |
1S/C8H16OS/c1-4-7-9-6-5-8(2,3)10-7/h7H,4-6H2,1-3H3 |
Inchi Key: |
MGCPAMUGCONVKI-UHFFFAOYSA-N |
Cas No: |
444880-09-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
182.26 |
Mass (g/mol) |
160.092 |
Molar Refractivity |
52.09 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
212.67 |
Vapor Pressure (mmHg@25.00 °C) |
0.249 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.91 |
LogP |
2.655 |
iLOGP |
2.42 |
XLOGP3 |
2.60 |
WLOGP |
2.66 |
MLOGP |
2.48 |
ESOL Log S |
-2.54 |
ESOL Solubility (mg/ml) |
0.523 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.80 |
Ali Solubility (mg/ml) |
0.29 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.56 |
Silicos-IT Solubility (mg/ml) |
0.51 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.57 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.687 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.981 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |